ESR1 and breast cancer: Tamoxifen, a non-steroidal anti-estrogen drug, is used in the treatment of estrogen receptor (ER)-positive breast cancer patients and as chemoprevention in high risk women [1] but is not effective against ER-negative breast tumours [2].